Learn more at LeadIQ.com

Insights

Gathering insights about genOway…

Similar companies to genOway

genOway Tech Stack

genOway uses 8 technology products and services including Hotjar, jsDelivr, CookieFirst, and more. Explore genOway's tech stack below.

Hotjar
Analytics
jsDelivr
Content Delivery Network
CookieFirst
Cookie Compliance
LottieFiles
Miscellaneous
Webflow
Page Builders
PHP
Programming Languages
Google Tag Manager
Tag Management
Nginx
Web Servers

Media & News

genOway SA partnered with Merck on Dec 1st '18.
In December 2018, genOway entered into an exclusive worldwide license agreement with Merck for the use of its foundational CRISPR integration patents for preclinical applications in the rodent field.
Jan 25, 2022 | www.prnewswire.com
Merck sold assets to genOway SA on Jan 1st '20.
- In 2020, GenOway acquired exclusive worldwide rights from Merck for its foundational CRISPR/Cas9 portfolio in the rodent field.
Jan 13, 2022 | www.emailwire.com
genOway SA is developing humanized immune checkpoint models.
genOway (EURONEXT GROWTHTM Paris; ISIN: FR0004053510), an innovative French company and leader in conceiving and developing genetically engineered preclinical research models, announces the obtention of €2,3M from the European Union and the Auvergne-Rhône-Alpes Region to develop humanized immune checkpoint (ICP) models.
Jan 04, 2021 | www.genoway.com
genOway SA partnered with Merck on Dec 1st '18.
genOway, a leading company in the development of genetically modified research models, has announced an important milestone in expanding its strategic alliance with Merck, a leading science company and technology and genome editing.
Jan 08, 2020 | biospectrumindia.com
genOway SA is developing models that enable scientists to use CRISPR/Cas9 genome editing technology.
As per the agreement – financial details of which were not disclosed – the France-based research model developer GenOway will license MilliporeSigma’s CRISPR integration patents to develop new models that enable scientists to use CRISPR/Cas9 genome editing technology.
Dec 19, 2018 | www.outsourcing-pharma.com
genOway SA is developing models and solutions.
Through an exclusive worldwide license of MilliporeSigma's foundational CRISPR integration patents, genOway will develop new models and solutions allowing non-profit and for-profit scientists to use CRISPR/Cas9 technology.
Dec 10, 2018 | www.prnewswire.com
Merck KGaA partners with genOway SA.
Darmstadt, Germany, December 10, 2018 - Merck, a leading science and technology company and leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.
Dec 09, 2018 | www.genoway.com

genOway's Email Address Formats

genOway uses at least 1 format(s):

genOway Email Formats	Example	Percentage
Last@genoway.com	Doe@genoway.com	67%
FLast@genoway.com	JDoe@genoway.com	13%
First@genoway.com	John@genoway.com	10%
First.Last@genoway.com	John.Doe@genoway.com	10%

Frequently Asked Questions

Where is genOway's headquarters located?

genOway's main headquarters is located at 31, Rue Saint-Jean-de-Dieu Lyon, Auvergne-Rhone-Alpes 69007 FR. The company has employees across 3 continents, including EuropeNorth AmericaSouth America.

What is genOway's phone number?

You can contact genOway's main corporate office by phone at

+33-4-37-65-4****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is genOway's official website and social media links?

genOway's official website is genoway.com and has social profiles on LinkedIn.

How much revenue does genOway generate?

As of September 2024, genOway's annual revenue reached $35M.

What is genOway's SIC code NAICS code?

genOway's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does genOway have currently?

As of September 2024, genOway has approximately 111 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Executive Officer: A. F.Chief Representative: O. E. A. M. C. D. B.Head Of Immunology: G. M.. Explore genOway's employee directory with LeadIQ.

What industry does genOway belong to?

genOway operates in the Biotechnology Research industry.

What technology does genOway use?

genOway's tech stack includes HotjarjsDelivrCookieFirstLottieFilesWebflowPHPGoogle Tag ManagerNginx.

What is genOway's email format?

genOway's email format typically follows the pattern of . Find more genOway email formats with LeadIQ.

When was genOway founded?

genOway was founded in 1999.

genOway

genOway

Biotechnology ResearchAuvergne-Rhône-Alpes, France51-200 Employees

Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.

Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. 

genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. 

Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.

Company Overview

Headquarters: 31, Rue Saint-Jean-de-Dieu Lyon, Auvergne-Rhone-Alpes 69007 FR
Phone number: ✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+33-4-37-65-4****
Website: genoway.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 1999
Employees: 51-200

Media & News

Funding & Financials

$10M$50M
genOway's revenue is in the range of $10M$50M

Funding & Financials

$10M$50M
genOway's revenue is in the range of $10M$50M

Company Leadership

A. F.
Chief Executive Officer
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
O. E. A. M. C. D. B.
Chief Representative
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. M.
Head Of Immunology
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. P.
Directeur Des Opérations / Coo
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. J. G.
Chairman Of The Board
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

Y. C.
Vp Technology Ansd Scientific Operations
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. M.
Head Of Immunology
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
O. E. A. M. C. D. B.
Chief Representative
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. P. C.
Director
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. S.
Director - Preclinical Models & Services
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for genOway and Millions of Other Companies
Sign up for full access to genOway information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.